I am not using enza (yet) wondering if it's worth taking some nutmeg to keep those mao in check anyway! 
The MAO inhibitors phenelzine and clo... - Fight Prostate Ca...
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma, Molecules. 2022 Jul; 27(13): 4297. Published online 2022 Jul 4
Not what you're looking for?
You may also like...
Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
New paper from Spain [1].
"... we will review those strategies and drugs that are able to...
Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer
Doctors in Perth, Australia are leading a Phase 3 clinical trial called ProstACT GLOBAL, which is...
The Role of HSD3B1 in Prostate Cancer Progression and Treatment
I don't think I was tested against this gene, so I think it could be important for me as well.
A...
Developments in the Continued Search for a Prostate Cancer Vaccine...
Greetings FPC members,
As some of you know, I believe that the development of a vaccine or vaccines...
The association between serum lipid profile and the prostate cancer risk and aggressiveness
New study from Korea [1].
"Men who underwent prostate biopsy between January 2005 and December...
Related Posts
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance, Int J Mol Sci. 2022 Nov; 23(21): 13521- Warming Up the Cold: A New Hope for Immunotherapy in Prostate Cancer
Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States
The Cancer Some Doctors No Longer Want To Call Cancer (Prostate). Sumathi Reddy is the author of the story in the Wall Street Journal.
Cancer and Atherosclerosis targeting, A New Blood test to guide treatment, Targeting drug resistance in PCa
